Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Tel Aviv
Ofer Merimsky
41 years of experience
accreditations :
Clinic is certified :
| Israel | Turkey | Austria | |
| Topical therapy of melanoma | - | from $1,450 | - |
Day 1
Day 2
Day 3
Day 4
Week 1
Week 2-4
Please note, each patient"s case is unique, and treatment plans may vary.
As the leading global medical tourism platform, Bookimed.com provides the most objective and transparent information about Topical therapy of melanoma and medical services in Israel. All the information provided on Bookimed.com is grounded in research, foresight, and expertise and meets high interest related to the product and follows:
We form our listings of clinics and doctors with strict regulations of our smart automatic ranking system based on real Bookimed patient rates to provide objective and transparent information about Topical therapy of melanoma clinics and medical services in Israel.
Our experienced data scientist collects data daily, monitors and optimizes the ranking system using machine learning and artificial intelligence to ensure that the ranking system is up-to-date and provides accurate results.
We collect the opinions of Bookimed clients only after getting medical experience with the clinic — so everyone on the platform can trust the facility they choose in Israel for Topical therapy of melanoma. We strive to make the content on our platform as useful as possible and ensure the freedom to express critical opinions. Thus, we publish positive and negative reviews, aiming at being a source for informed decision-making for our future clients.
On Bookimed.com you may find choice and convenience to find the best medical solutions from top medical services providers in Israel for Topical therapy of melanoma just in one place, and often at competitive prices. Making sure to deliver the freshest information, the clinic’s representatives update doctors’ CVs, clinics’ capacities, before-after pictures, prices, packages, and specials by themselves shortly. You may meet the clinic’s representative and check the date of updated content at every clinic’s page to make sure of its trustworthiness.
Our blog and supportive pieces are created by professional authors with at least 3-year experience in medical writing and edited by medical specialists with relevant clinical and research expertise — all carefully recruited to the team. We strive to enhance patient access to health information, making it expert but easy to understand. All pieces follow the Bookimed’s Editorial Guidelines.
We are made of people and for people — and that"s our core value. That"s why all the data presented on the platform is collected, edited, reviewed, and updated regularly by our patients, our partner clinics, and our team, including the Bookimed Medical Advisory Board, which consists of the world-renowned doctors with value expertise over 20 years of practice, and a positive reputation. Learn more about us and our mission.
In case you find any mistake or have any questions on the information presented on Bookimed.com, please feel free to contact us at marketing@bookimed.com.
Dr. Merimsky heads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center, specializing in complex melanoma treatments.
Dr. Dov Zippel is a surgical oncologist and head of the Meirav Breast Center. Forbes Israel named him to its Best Doctors list in 2025. He treats benign and malignant breast tumors and melanoma at Sheba Medical Center. Dr. Zippel completed a surgical oncology fellowship at the University of Calgary in Canada.
Dr. Yosi Alkalay is the pioneer of micrographic surgery in Israel. Based at Assuta Medical Center, he specializes in the MOHS method for skin cancer. He treats oncopathologies, hemangiomas, and various skin conditions. Dr. Alkalay earned his medical degree from the Houston Cancer Center in the USA.
Topical therapies for melanoma in Israel are primarily used for melanoma in situ or early-stage lesions when surgery is not feasible. Israeli specialists utilize immune response modifiers like Imiquimod and photodynamic therapy to stimulate the bodys immune system and destroy malignant cells while sparing healthy tissue.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center treat over 40,000 patients annually using advanced diagnostics. While topical creams provide non-invasive options for Stage 0 cases, Israeli research focuses more on systemic immunotherapy and targeted treatments. Experts like Dr. Dov Zippel emphasize that surgical excision remains the definitive gold standard for invasive melanoma.
Patient Consensus: Patients often clarify that topical creams are usually reserved for precancerous spots or field therapy. Most recommend seeking specialized surgical consultations at accredited clinics to ensure the most effective treatment for invasive types.
Topical therapies treat early-stage, non-invasive melanomas on the skin surface. They primarily target melanoma in situ (Stage 0) and lentigo maligna when surgery is not feasible. These creams stimulate the local immune system to destroy superficial cancer cells without invasive surgical excision.
Bookimed Expert Insight: Israeli specialists like Dr. Ofer Merimsky at Sourasky Medical Center prioritize multidisciplinary review before choosing topicals. While surgery is the standard, topicals are strategically used for field cancerization. This approach treats large sun-damaged areas rather than just individual spots to prevent future recurrences.
Patient Consensus: Patients emphasize that topicals are never for invasive types and require strict specialist oversight. Many report using them only when surgeries like Mohs or wide excision aren't viable options.
Israel is a global leader in advanced local melanoma therapies, offering specialized treatments like Tumor-Infiltrating Lymphocyte (TIL) therapy, Alpha-Radiation Implants (DaRT), and isolated limb perfusion. Institutions like Sheba Medical Center and Sourasky Medical Center utilize JCI-accredited protocols to treat advanced or treatment-resistant metastatic cases.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center manage high volumes, treating 40,000 cancer patients annually. This massive scale allows doctors like Dr. Ofer Merimsky to refine protocols for rare thoracic or soft tissue melanoma cases. Choosing a center with specialized surgical oncologists who offer both isolated limb infusion and DaRT technology typically provides more comprehensive local control options.
Patient Consensus: Patients emphasize that while TIL therapy represents a vital pathway when standard immunotherapy fails, the process is physically intensive and requires preparation for significant recovery time. Early verification of total costs is recommended as advanced biological treatments in Israel require substantial financial planning.
Early-stage melanoma (stages 0-2) at Sourasky Medical Center (Ichilov) is primarily treated with wide local excision and sentinel lymph node biopsy. Surgeons utilize precise diagnostic tools like Foundation One CDX genetic testing and Novalis TrueBeam STx to ensure accurate staging and 90% cancer treatment success rates.
Bookimed Expert Insight: While patients often search for topical therapies, Sourasky oncology specialists prioritize surgery as the first-line intervention. Their massive volume of 40,000 cancer patients yearly reinforces why they rely on excision over experimental non-surgical methods. Successful outcomes here often depend on their 90% overall success rate across complex oncological cases. You should ask your coordinator if Foundation One testing is necessary for your specific stage.
Patient Consensus: Patients emphasize the importance of comprehensive diagnostics like PET scans or brain MRIs to confirm early-stage status. They often seek peace of mind from the high success rates reported at this Tel Aviv facility.
Choosing Israel for melanoma therapy provides access to world-leading expertise in personalized immunology and innovative diagnostic technologies. JCI-accredited centers like Sourasky Medical Center and Assuta utilize advanced genetic testing and precision surgery, offering outcomes underpinned by clinical trials often unavailable elsewhere.
Bookimed Expert Insight: Israeli oncology centers like Sourasky manage over 40,000 cancer patients annually, creating a massive data pool for treatment optimization. This volume allows surgeons to refine precision techniques like Mohs surgery and sentinel node biopsies far more quickly than in general hospitals elsewhere. While topical creams are rarely used for melanoma, Israel leads in developing local delivery systems like alpha-radiation implants and nano-carriers that target tumors directly.
Patient Consensus: Patients emphasize the importance of choosing established systemic treatments like immunotherapy over topical creams. Expert consensus suggests prioritizing surgical excision or clinical trials when treating confirmed melanoma cases.